See more : Candy Club Holdings Limited (CLB.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Chemed Corporation (CHE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Chemed Corporation, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Aarvee Denims and Exports Ltd. (AARVEEDEN.NS) Income Statement Analysis – Financial Results
- Alue Co.,Ltd. (7043.T) Income Statement Analysis – Financial Results
- Hanchang Corporation (005110.KS) Income Statement Analysis – Financial Results
- The Healing Company Inc. (HLCO) Income Statement Analysis – Financial Results
- Advani Hotels & Resorts (India) Limited (ADVANIHOTR.BO) Income Statement Analysis – Financial Results
Chemed Corporation (CHE)
About Chemed Corporation
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.26B | 2.13B | 2.14B | 2.08B | 1.94B | 1.78B | 1.67B | 1.58B | 1.54B | 1.46B | 1.41B | 1.43B | 1.36B | 1.28B | 1.19B | 1.15B | 1.10B | 1.02B | 926.48M | 735.34M | 308.87M | 314.18M | 477.12M | 500.69M | 453.60M | 381.30M | 341.70M | 683.80M | 699.20M | 645.00M | 525.10M | 401.00M | 352.30M | 599.40M | 591.80M | 500.60M | 391.00M | 359.50M | 372.70M |
| Cost of Revenue | 1.47B | 1.37B | 1.37B | 1.38B | 1.32B | 1.23B | 1.15B | 1.12B | 1.09B | 1.03B | 1.01B | 1.03B | 970.48M | 906.02M | 834.57M | 810.55M | 767.07M | 730.12M | 651.84M | 507.08M | 182.81M | 186.29M | 295.48M | 295.54M | 269.80M | 230.50M | 206.00M | 436.50M | 457.40M | 422.60M | 344.90M | 259.60M | 227.00M | 315.20M | 309.00M | 244.20M | 162.30M | 147.40M | 152.90M |
| Gross Profit | 796.55M | 765.09M | 769.80M | 701.39M | 617.43M | 554.00M | 516.19M | 461.45M | 455.78M | 421.61M | 404.52M | 396.72M | 385.49M | 374.53M | 355.66M | 338.39M | 332.99M | 288.46M | 274.64M | 228.26M | 126.06M | 127.89M | 181.64M | 205.15M | 183.80M | 150.80M | 135.70M | 247.30M | 241.80M | 222.40M | 180.20M | 141.40M | 125.30M | 284.20M | 282.80M | 256.40M | 228.70M | 212.10M | 219.80M |
| Gross Profit Ratio | 35.18% | 35.84% | 35.98% | 33.73% | 31.85% | 31.08% | 30.97% | 29.26% | 29.53% | 28.95% | 28.62% | 27.74% | 28.43% | 29.25% | 29.88% | 29.45% | 30.27% | 28.32% | 29.64% | 31.04% | 40.81% | 40.71% | 38.07% | 40.97% | 40.52% | 39.55% | 39.71% | 36.17% | 34.58% | 34.48% | 34.32% | 35.26% | 35.57% | 47.41% | 47.79% | 51.22% | 58.49% | 59.00% | 58.98% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 322.92M | 358.73M | 366.73M | 330.22M | 305.71M | 270.21M | 276.65M | 243.57M | 237.82M | 220.12M | 212.52M | 208.66M | 202.26M | 201.96M | 197.43M | 175.33M | 184.06M | 161.18M | 151.67M | 138.29M | 105.90M | 95.51M | 146.71M | 148.23M | 136.90M | 113.40M | 100.90M | 197.20M | 190.60M | 177.60M | 143.90M | 117.00M | 107.70M | 226.40M | 211.60M | 194.20M | 169.50M | 159.10M | 162.50M |
| Selling & Marketing | 72.20M | 68.60M | 62.10M | 54.40M | 49.50M | 47.00M | 40.90M | 37.20M | 36.40M | 32.80M | 31.00M | 29.20M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 395.12M | 358.73M | 366.73M | 330.22M | 305.71M | 270.21M | 276.65M | 243.57M | 237.82M | 220.12M | 212.52M | 208.66M | 202.26M | 201.96M | 197.43M | 175.33M | 184.06M | 161.18M | 151.67M | 138.29M | 105.90M | 95.51M | 146.71M | 148.23M | 136.90M | 113.40M | 100.90M | 197.20M | 190.60M | 177.60M | 143.90M | 117.00M | 107.70M | 226.40M | 211.60M | 194.20M | 169.50M | 159.10M | 162.50M |
| Other Expenses | 60.87M | 62.86M | 60.04M | -18.51M | 54.34M | 287.00K | 8.43M | 2.06M | -270.00K | 3.19M | 4.94M | 3.66M | 29.50M | 29.04M | 31.89M | 27.51M | 26.18M | 22.30M | 43.58M | 31.87M | 12.05M | 13.59M | 16.11M | 23.45M | 20.10M | 17.30M | 15.20M | 18.80M | 18.20M | 15.80M | 13.10M | 9.20M | 8.10M | 23.10M | 21.70M | 19.30M | 16.50M | 14.60M | 13.90M |
| Operating Expenses | 455.99M | 421.59M | 426.77M | 311.71M | 360.05M | 310.37M | 403.16M | 282.70M | 271.32M | 253.19M | 244.91M | 240.30M | 231.76M | 231.01M | 229.32M | 205.54M | 210.24M | 183.49M | 195.25M | 170.16M | 117.95M | 109.10M | 162.82M | 171.68M | 157.00M | 130.70M | 116.10M | 216.00M | 208.80M | 193.40M | 157.00M | 126.20M | 115.80M | 249.50M | 233.30M | 213.50M | 186.00M | 173.70M | 176.40M |
| Cost & Expenses | 1.92B | 1.79B | 1.80B | 1.69B | 1.68B | 1.54B | 1.55B | 1.40B | 1.36B | 1.29B | 1.25B | 1.27B | 1.20B | 1.14B | 1.06B | 1.02B | 977.30M | 913.61M | 847.09M | 677.24M | 300.76M | 295.38M | 458.30M | 467.22M | 426.80M | 361.20M | 322.10M | 652.50M | 666.20M | 616.00M | 501.90M | 385.80M | 342.80M | 564.70M | 542.30M | 457.70M | 348.30M | 321.10M | 329.30M |
| Interest Income | 6.27M | 355.00K | 377.00K | 757.00K | 513.00K | 671.00K | 427.00K | 383.00K | 281.00K | 0.00 | 847.00K | 809.00K | 426.00K | 444.00K | 423.00K | 743.00K | 3.30M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 3.11M | 4.58M | 1.87M | 2.36M | 4.54M | 4.99M | 4.27M | 3.72M | 3.65M | 8.22M | 15.04M | 14.72M | 13.89M | 11.96M | 11.60M | 5.99M | 11.24M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 60.87M | 59.17M | 59.05M | 56.58M | 45.21M | 38.86M | 35.63M | 34.64M | 33.50M | 33.07M | 32.39M | 30.52M | 29.50M | 29.04M | 27.90M | 27.51M | 26.57M | 23.80M | 23.34M | 20.18M | 12.81M | 14.36M | 24.12M | 23.45M | 20.10M | 17.30M | 15.20M | 18.80M | 18.20M | 15.80M | 13.10M | 9.20M | 8.10M | 23.10M | 21.70M | 19.30M | 16.50M | 14.60M | 13.90M |
| EBITDA | 414.34M | 393.44M | 411.23M | 454.93M | 311.35M | 283.45M | 156.81M | 215.41M | 217.27M | 200.62M | 162.17M | 191.06M | 183.94M | 174.83M | 160.12M | 155.84M | 138.47M | 126.28M | 99.68M | 78.14M | 18.60M | 27.72M | 37.23M | 52.94M | 46.90M | 37.40M | 34.80M | 29.20M | 51.20M | 44.80M | 36.30M | 24.40M | 17.60M | 57.80M | 71.20M | 62.20M | 59.20M | 53.00M | 57.30M |
| EBITDA Ratio | 18.30% | 18.43% | 19.22% | 21.88% | 16.06% | 15.90% | 9.45% | 13.69% | 14.12% | 14.06% | 13.99% | 13.38% | 13.51% | 13.48% | 12.96% | 13.56% | 14.83% | 12.40% | 13.80% | 12.47% | 8.25% | 16.01% | 13.92% | 10.07% | 7.91% | 4.88% | 4.62% | 2.21% | 4.96% | 5.47% | 3.87% | 2.47% | 0.62% | 9.19% | 11.41% | 11.95% | 14.32% | 17.80% | 13.31% |
| Operating Income | 340.57M | 343.50M | 343.04M | 389.68M | 257.38M | 243.63M | 113.04M | 178.75M | 184.46M | 168.42M | 133.39M | 156.42M | 153.73M | 143.52M | 126.35M | 132.86M | 122.76M | 104.98M | 79.38M | 58.11M | -7.72M | -1.55M | 18.82M | 33.47M | 26.80M | 20.10M | 19.60M | 31.30M | 33.00M | 29.00M | 23.20M | 15.20M | 9.50M | 34.70M | 49.50M | 42.90M | 42.70M | 38.40M | 43.40M |
| Operating Income Ratio | 15.04% | 16.09% | 16.04% | 18.74% | 13.28% | 13.67% | 6.78% | 11.34% | 11.95% | 11.56% | 9.44% | 10.94% | 11.34% | 11.21% | 10.62% | 11.56% | 11.16% | 10.31% | 8.57% | 7.90% | -2.50% | -0.49% | 3.94% | 6.68% | 5.91% | 5.27% | 5.74% | 4.58% | 4.72% | 4.50% | 4.42% | 3.79% | 2.70% | 5.79% | 8.36% | 8.57% | 10.92% | 10.68% | 11.64% |
| Total Other Income/Expenses | 9.80M | -13.82M | 7.28M | 6.31M | 4.23M | -4.03M | 3.88M | -1.70M | -4.33M | -5.67M | -9.57M | -12.94M | -13.17M | -9.69M | -5.73M | -10.51M | -20.92M | -14.70M | -24.73M | -21.02M | 7.67M | -18.42M | -29.15M | -2.54M | 4.20M | 12.00M | 8.30M | 11.00M | 3.00M | -3.50M | 3.20M | 5.60M | 6.90M | -7.70M | -8.10M | -8.60M | -5.60M | -22.60M | -2.90M |
| Income Before Tax | 350.37M | 329.68M | 350.31M | 395.99M | 261.61M | 239.60M | 116.92M | 177.05M | 180.13M | 162.75M | 123.83M | 145.82M | 140.56M | 133.83M | 120.62M | 122.35M | 101.84M | 90.28M | 57.28M | 37.09M | 1.25M | -1.28M | -10.06M | 33.25M | 31.00M | 32.10M | 27.90M | 53.60M | 36.00M | 25.50M | 26.40M | 20.80M | 16.40M | 27.00M | 41.40M | 34.30M | 37.10M | 15.80M | 40.50M |
| Income Before Tax Ratio | 15.47% | 15.44% | 16.38% | 19.04% | 13.50% | 13.44% | 7.01% | 11.23% | 11.67% | 11.18% | 8.76% | 10.20% | 10.37% | 10.45% | 10.13% | 10.65% | 9.26% | 8.86% | 6.18% | 5.04% | 0.40% | -0.41% | -2.11% | 6.64% | 6.83% | 8.42% | 8.17% | 7.84% | 5.15% | 3.95% | 5.03% | 5.19% | 4.66% | 4.50% | 7.00% | 6.85% | 9.49% | 4.39% | 10.87% |
| Income Tax Expense | 77.86M | 80.06M | 81.76M | 76.52M | 41.69M | 34.06M | 18.74M | 68.31M | 69.85M | 63.44M | 46.60M | 56.52M | 54.58M | 52.00M | 46.58M | 50.24M | 39.06M | 32.56M | 19.58M | 13.80M | 4.75M | 6.85M | -3.36M | 12.66M | 11.30M | 12.20M | 10.80M | 21.90M | 15.60M | 11.00M | 9.30M | 6.50M | 5.40M | 10.40M | 15.20M | 13.70M | 16.70M | 9.00M | 18.60M |
| Net Income | 272.51M | 249.62M | 268.55M | 319.47M | 219.92M | 205.54M | 98.18M | 108.74M | 110.27M | 99.32M | 77.23M | 89.30M | 85.98M | 81.83M | 73.78M | 71.02M | 63.98M | 50.65M | 35.82M | 27.51M | -3.44M | -1.81M | -10.38M | 20.58M | 19.70M | 19.90M | 30.30M | 32.30M | 23.10M | 43.90M | 19.50M | 15.70M | 52.90M | 16.60M | 26.20M | 21.90M | 20.40M | 36.80M | 21.90M |
| Net Income Ratio | 12.03% | 11.69% | 12.55% | 15.36% | 11.34% | 11.53% | 5.89% | 6.90% | 7.14% | 6.82% | 5.46% | 6.24% | 6.34% | 6.39% | 6.20% | 6.18% | 5.82% | 4.97% | 3.87% | 3.74% | -1.11% | -0.58% | -2.17% | 4.11% | 4.34% | 5.22% | 8.87% | 4.72% | 3.30% | 6.81% | 3.71% | 3.92% | 15.02% | 2.77% | 4.43% | 4.37% | 5.22% | 10.24% | 5.88% |
| EPS | 18.11 | 16.72 | 17.14 | 20.02 | 13.77 | 12.80 | 6.11 | 6.64 | 6.54 | 5.79 | 4.24 | 4.72 | 4.19 | 3.62 | 3.29 | 3.08 | 2.61 | 1.94 | 1.40 | 1.14 | -0.17 | -0.09 | -0.53 | 1.01 | 0.93 | 0.99 | 1.52 | 1.65 | 1.18 | 2.23 | 1.00 | 0.80 | 2.64 | 0.80 | 1.31 | 1.19 | 1.14 | 2.06 | 1.25 |
| EPS Diluted | 17.93 | 16.53 | 16.85 | 19.48 | 13.31 | 12.23 | 5.86 | 6.48 | 6.33 | 5.57 | 4.16 | 4.62 | 4.10 | 3.55 | 3.24 | 3.04 | 2.55 | 1.90 | 1.36 | 1.12 | -0.17 | -0.09 | -0.53 | 1.00 | 0.93 | 0.99 | 1.51 | 1.63 | 1.18 | 2.23 | 1.00 | 0.80 | 2.64 | 0.80 | 1.27 | 1.14 | 1.08 | 1.80 | 1.14 |
| Weighted Avg Shares Out | 15.05M | 14.93M | 15.67M | 15.96M | 15.97M | 16.06M | 16.06M | 16.38M | 16.87M | 17.17M | 18.20M | 18.92M | 20.52M | 22.59M | 22.45M | 23.06M | 24.52M | 26.12M | 25.55M | 24.12M | 19.85M | 19.72M | 19.43M | 19.67M | 20.94M | 20.12M | 19.88M | 19.58M | 19.72M | 19.71M | 19.60M | 19.63M | 20.08M | 20.75M | 20.08M | 18.48M | 17.89M | 17.86M | 17.59M |
| Weighted Avg Shares Out (Dil) | 15.20M | 15.10M | 15.94M | 16.40M | 16.53M | 16.80M | 16.74M | 16.79M | 17.42M | 17.84M | 18.59M | 19.34M | 20.95M | 23.03M | 22.74M | 23.37M | 25.08M | 26.67M | 26.30M | 24.64M | 19.91M | 19.77M | 19.43M | 19.85M | 21.03M | 20.20M | 20.03M | 19.82M | 19.72M | 19.71M | 19.60M | 19.63M | 20.08M | 20.75M | 20.63M | 19.30M | 18.98M | 20.44M | 19.30M |
Chemed Corporation to Present at the BofA Securities 2024 Virtual Home Care Conference
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will present at the BofA Securities 2024 Virtual Home Care Conference on Tuesday, December 10, 2024, at 1:20 PM (ET). The presentation will be webcast live and can be accessed, along with...
EHC vs. CHE: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Encompass Health (EHC) and Chemed (CHE). But which of these two stocks presents investors with the better value opportunity right now?
Chemed Stock Hurt by Roto-Rooter Softness, Macro Issues Dent Growth
The ongoing global economic conditions, such as general labor, supply chain and inflationary pressure, along with political and regulatory developments, are escalating expenses for CHE.
Chemtrade Logistics Income Fund (CGIFF) Q3 2024 Earnings Call Transcript
Chemtrade Logistics Income Fund (OTC:CGIFF) Q3 2024 Earnings Conference Call November 15, 2024 10:00 AM ET Company Participants Rohit Bhardwaj - CFO Scott Rook - President and CEO Conference Call Participants Steve Hansen - Raymond James Joel Jackson - BMO...
Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 50 Cents
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $300 million for stock repurchase under Chemed's existing share repurchase program. These share repurchases will be funded through a combination of cash generated from...
Chemed Corporation to Present at the UBS 2024 Global Healthcare Conference
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) today announced that it will deliver a presentation at the UBS 2024 Global Healthcare Conference on Tuesday, November 12, 2024, at approximately 2:45 p.m. (ET) at the Terranea Resort in Rancho Palos Verdes, California. The...
AMED or CHE: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Amedisys (AMED) and Chemed (CHE). But which of these two companies is the best option for those looking for undervalued stocks?
Chemed Corporation (CHE) Q3 2024 Earnings Call Transcript
Chemed Corporation (NYSE:CHE ) Q3 2024 Earnings Conference Call October 30, 2024 10:00 AM ET Company Participants Holley Schmidt - Assistant Controller Kevin McNamara - President and Chief Executive Officer Mike Witzeman - Chief Financial Officer Nick Westfall - Chairman...
CHE Misses on Q3 Earnings, Lowers '24 EPS View, Stock Up
Chemed's VITAS segment reports impressive revenue growth and margin expansion for the third quarter of 2024.
Chemed (CHE) Lags Q3 Earnings and Revenue Estimates
Chemed (CHE) came out with quarterly earnings of $5.64 per share, missing the Zacks Consensus Estimate of $5.76 per share. This compares to earnings of $5.32 per share a year ago.
Source: https://incomestatements.info
Category: Stock Reports